Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Change in Accured Expenses (2019 - 2025)

Historic Change in Accured Expenses for Nutex Health (NUTX) over the last 7 years, with Q3 2025 value amounting to $347000.0.

  • Nutex Health's Change in Accured Expenses fell 9441.76% to $347000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.7 million, marking a year-over-year decrease of 11126.7%. This contributed to the annual value of $12.5 million for FY2024, which is 11346.79% up from last year.
  • Latest data reveals that Nutex Health reported Change in Accured Expenses of $347000.0 as of Q3 2025, which was down 9441.76% from $2.9 million recorded in Q2 2025.
  • Over the past 5 years, Nutex Health's Change in Accured Expenses peaked at $9.4 million during Q2 2022, and registered a low of -$6.9 million during Q3 2022.
  • In the last 5 years, Nutex Health's Change in Accured Expenses had a median value of $1.9 million in 2023 and averaged $1.3 million.
  • The largest annual percentage gain for Nutex Health's Change in Accured Expenses in the last 5 years was 1580646.08% (2021), contrasted with its biggest fall of 99204.0% (2021).
  • Quarter analysis of 5 years shows Nutex Health's Change in Accured Expenses stood at $2.8 million in 2021, then plummeted by 246.02% to -$4.0 million in 2022, then skyrocketed by 58.4% to -$1.7 million in 2023, then plummeted by 152.11% to -$4.2 million in 2024, then skyrocketed by 108.22% to $347000.0 in 2025.
  • Its Change in Accured Expenses was $347000.0 in Q3 2025, compared to $2.9 million in Q2 2025 and -$769000.0 in Q1 2025.